Clinical trials
Phase 1 Tuberculosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
160 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 9 |
| 2008 | 12 |
| 2009 | 10 |
| 2010 | 12 |
| 2011 | 5 |
| 2012 | 7 |
| 2013 | 8 |
| 2014 | 3 |
| 2015 | 12 |
| 2016 | 7 |
| 2017 | 10 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 131 |
| Unknown status | 8 |
| Terminated | 7 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Withdrawn | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Oxford | 27 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 20 |
| Global Alliance for TB Drug Development | 14 |
| Aeras | 12 |
| Statens Serum Institut | 7 |
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 6 |
| GlaxoSmithKline | 6 |
| National University Hospital, Singapore | 5 |
| Sequella, Inc. | 3 |
| Tibotec BVBA | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 160 |
| Tuberculosis, Pulmonary | 17 |
| HIV Infections | 9 |
| Acquired Immunodeficiency Syndrome | 5 |
| Tuberculosis, Multidrug-Resistant | 5 |
| Lung Diseases | 4 |
| Mycobacterium Infections | 4 |
| AIDS-Related Opportunistic Infections | 3 |
| Adenoviridae Infections | 2 |
| Bacterial Infections | 2 |
Trials
Showing 1 to 25 of 160. Each trial links to its page on Pharma Observatory.
60 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.